2 recruiting, 1 terminated. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Terminated 1 |
Follow DEAE-Dextran: new trials by email Literature Review of DEAE-Dextran trials Research Report on DEAE-Dextran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer PULSAR (Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy), PULSAR - Gastric Adenocarcinoma, Stomach Neoplasms | Not applicable | Recruiting | Samsung Medical Center | 53 | 2026-05-15 | 2026-05-28 |
| Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) Personalized ultrafractionated stereotactic adaptive radiotherapy, Volume Modulated Arc Therapy, Computed Tomography - Head and Neck Carcinoma, Localized Head and Neck Carcinoma | Not applicable | Recruiting | Jonsson Comprehensive Cancer Center | 43 | 2024-10-25 | 2026-02-05 |
| Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer personalized ultrafractionated stereotactic ablative radiotherapy - Bladder Cancer | Not applicable | Terminated | University of Texas Southwestern Medical Center | 1 | 2021-09-06 | 2024-02-06 |
Lymphatic Metastasis (1) · Stomach Neoplasms (1) · Urinary Bladder Neoplasms (1)
Jonsson Comprehensive Cancer Center (1) · Samsung Medical Center (1) · University of Texas Southwestern Medical Center (1)
United States (2) · South Korea (1)
Solomon L Woldu, MD (1) · Travis Courtney, MD (1)